Jul 2026· Advancement of science· 1 citation· 38 references
Medicine
TL;DR
This study presents a promising ternary synergistic strategy for eradicating biofilms, potentially improving clinical outcomes in wound infection management and Transcriptomic profiling suggests stress‐response signatures consistent with oxidative/thermal injury.
Abstract
ABSTRACT Biofilms, a major cause of chronic bacterial infections, present significant treatment challenges due to their protective extracellular matrix that shields bacteria from both antibiotics and host immune defenses. To treat biofilms more effectively, here we discovered a biofilm‐binding peptide from a phage library and verified that it selectively bound the polysaccharides on the biofilm. We then engineered M13 phage into trifunctional nanofibers displaying the biofilm‐binding peptide at the tip and carrying gold nanoparticles (AuNPs, as photothermal agents) and tetrakis(4‐carboxyphenyl) porphyrin (TCPP, as a photosensitizer) on the sidewall for combined phototherapy. This design enhances binding/anchoring and eradication of biofilms by leveraging the unique properties of each component. The phage nanofibers efficiently bound biofilms and promoted the transfer of heat and penetration of reactive oxygen species (ROS) into the biofilm, leading to cell death. Therefore, under light irradiation, the engineered phage nanofibers effectively eradicated the biofilms by AuNP‐induced photothermal therapy (PTT) and TCPP‐assisted photodynamic therapy (PDT) in a biofilm‐associated skin wound model. Transcriptomic profiling suggests stress‐response signatures consistent with oxidative/thermal injury. This study presents a promising ternary synergistic strategy for eradicating biofilms, potentially improving clinical outcomes in wound infection management.
This review establishes a consolidated evidence base for the design of next-generation antimicrobial nanoformulations, highlights their potential to address biofilm-associated infections, and identifies key knowledge gaps and translation barriers that must be addressed to realize their therapeutic promise.
Praveen Kumar Annagowni, Renuka Gudepu, S. Dahariya et al.· Micro· 0 citations
OBJECTIVE
Chronic infections are often sustained by biofilms, which exhibit high tolerance to antimicrobials and immune clearance. Ultrasound (US)-stimulated microbubbles (MBs) have shown promise for biofilm disruption, yet their integration with chemical anti-biofilm agents and antibiotics has not been systematically...
Aaron Crowther, Sara B. Keller, Gareth LuTheryn et al.· Ultrasound in Medicine and B...· 0 citations
Hollow copper sulfide nanoparticles with a strong photothermal effect were employed as carriers for the loading of the NO-releasing bioactive molecule S-nitrosoglycine, which offers an innovative nanotherapeutic strategy for the precise treatment of drug-resistant bacterial infections.
Xiangjun Chen, Sai Zhang, Ya-Ting Liu et al.· Small· 1 citation
Chronic wound infections caused by multidrug-resistant (MDR) bacteria present a serious global health challenge. Clinical treatment outcomes are significantly impeded by two critical pathological barriers: stubborn bacterial biofilms that block antimicrobial penetration, and a highly oxidative, inflammatory microenviro...
Biofilm-associated infections remain refractory to antibiotics due to the extracellular polymeric substance (EPS) barrier limiting drug penetration and promoting drug resistance genes transfer. Deoxyribonuclease I (DNase I)-based strategies designed to degrade the EPS scaffold paradoxically fail within the biofilm micr...
Rui Wang, Yan Song, Jun-Jia Zeng et al.· Advanced Healthcare Material...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.